tizanidine
- Product NDC
- 70518-0774
- 11-digit product format
- 705180774
- Labeler code
- 70518
- Product ID
- 70518-0774_a588d00b-3c2a-2518-e053-2a95a90ad23c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA076533
- Marketing category
- ANDA
- Marketing start
- 2017-10-10
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-0774-2 | 70518077402 | 60 TABLET in 1 BOTTLE, PLASTIC (70518-0774-2) | 60 tablet | 2017-11-10 | 0000-00-00 | No | No | Current |